Marker Therapeutics, Inc.

News

TapImmune Provides Operational Update including Human Data Supporting Use of TAP Based Cancer Vaccine Company Establishes Laboratory Facilities in Vancouver Canada

ANCOUVER, Canada, 31 July, 2007 – TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, opens new laboratory facilities and provides this update to shareholders.
Read More

TapImmune Inc. Announces Availability of New Investor Information

VANCOUVER, British Columbia, July 17, 2007 (PRIME NEWSWIRE) — TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has launched a new corporate website with links to media features on its technologies.
Read More

TapImmune Inc. Announces Acquisition of Core TAP Technologies and Intellectual Property from The University of British Columbia

New Name to Reflect a New Direction and Independent Operation VANCOUVER, BC – TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has fulfilled its financial obligation to The University of British Columbia for the proposed acquisition of its key Transporter Associated with Antigen Processing (TAP) technology platform and patents.
Read More

TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma

Qian-Jin Zhang, Robyn P. Seipp, Susan S. Chen, Timothy Z. Vitalis, Xiao-Lin Li1, Kyung-Bok Choi, Andrew Jeffries, and Wilfred A. Jefferies http://www3.interscience.wiley.com/cgi-bin/abstract/114110086/ABSTRACT
Read More

Using the TAP Component of the Antigen-Processing Machinery as a Molecular Adjuvant

Timothy Z. Vitalis, Qian-Jin Zhang, Judie Alimonti, Susan S. Chen, Genc Basha, Alex Moise, Jacqueline Tiong, Mei Mei Tian, Kyung Bok Choi, Douglas Waterfield, Andy Jeffries, Wilfred A. Jefferies http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1323471/?report=abstract
Read More

Restoration of the Expression of Transporters Associated with Antigen Processing in Lung Carcinoma Increases Tumor-Specific Immune Responses and Survival

Yuanmei Lou, Timothy Z. Vitalis, Genc Basha, Bing Cai, Susan S. Chen, Kyung Bok Choi, Andrew P. Jeffries, W. Mark Elliott, Derek Atkins, Barbara Seliger, and Wilfred A. Jefferies http://cancerres.aacrjournals.org/content/65/17/7926.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Vitalis%252C+T&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Read More

Identification of Mechanisms Underlying Transporter Associated with Antigen Processing Deficiency in Metastatic Murine Carcinomas

A. Francesca Setiadi, Muriel D. David, Susan S. Chen, John Hiscott and Wilfred A. Jefferies http://cancerres.aacrjournals.org/content/65/16/7485.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Jefferies%252C+W&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Read More

CTL-Dependent and -Independent Antitumor Immunity Is Determined by the Tumor Not the Vaccine

Jaina Leitch, Katie Fraser, Cecilia Lane, Kelley Putzu, Gosse J. Adema, Qian-Jin Zhang, Wilfred A. Jefferies, Jonathan L. Bramson and Yonghong Wan http://www.jimmunol.org/content/172/9/5200.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&author1=Jefferies%252C+W&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&fdate=1/1/2004&tdate=12/31/2004&resourcetype=HWCIT
Read More

TAP expression provides a general method for improving the recognition of malignant cells in vivo

Judy Alimonti, Qian-Jin Zhang, Reinhard Gabathuler, Gregor Reid, Susan S. Chen, and Wilfred A. Jefferies http://www.nature.com/nbt/journal/v18/n5/abs/nbt0500_515.html
Read More